Steen Agency and Microsoft highlight BrainChild’s progress

Hammarö, Sweden – Feb 11, 2026 – Microsoft has published a new customer story highlighting BrainChild and the growing role of genomic data, AI and precision medicine in Swedish healthcare.

The story, Turning Genomic Data into Clinical Impact, explores how BrainChild — a pioneering initiative supported by Genomic Medicine Sweden (GMS) — is helping bridge the gap between research and clinical care through secure, large-scale use of genomic and clinical data.

At the center of the story is Filippa, a young patient whose treatment journey demonstrates the real-world impact precision medicine can have when genomic analysis is combined with modern data infrastructure and targeted therapies.

The story also highlights the broader vision behind BrainChild: creating a future where genomic insights, AI and structured healthcare data can help clinicians make faster, more informed decisions while maintaining the highest standards of patient privacy and ethics.

Making complex healthcare innovation human

Steen Agency was responsible for the storytelling and production surrounding the initiative, continuing its long-term collaboration with Microsoft within healthcare and socially important innovation projects.

“BrainChild represents the kind of story we believe deeply in as an agency,” says Lars-Petter Steen, Founder and Business Director at Steen Agency.

“This is not technology for technology’s sake. These are real people, real families and real clinical outcomes. Our role has been to make an incredibly complex topic emotionally accessible without losing the scientific credibility behind it.”

The production builds on Steen Agency’s documentary-driven approach to B2B storytelling, where emotional authenticity and cinematic craft are used to communicate complex societal and technological transformation.

A new era of precision medicine

The story also reflects Microsoft’s broader commitment to supporting healthcare innovation through data, AI and cloud technology.

“Sweden has a unique opportunity to become a global leader in precision medicine,” says AnnMarie Löfberg, Marketing Manager, Nordics / Health & Life Sciences at Microsoft.

“What makes BrainChild so important is the collaboration between healthcare, research and technology. By structuring and connecting data responsibly, we can create entirely new possibilities for diagnostics, treatment and long-term patient outcomes.”

The BrainChild initiative aims to create infrastructure that allows genomic, radiology, pathology and clinical data to work together in a secure and scalable way — enabling healthcare providers to move from fragmented information toward real-time clinical insights.

The story is published here: https://pulse.microsoft.com/sv-se/transform-sv-se/healthcare-sv-se/fa1-turning-genomic-data-into-clinical-impact/

About Steen Agency

Steen Agency is a Swedish B2B storytelling and communications agency specialising in emotionally driven communication for technology, healthcare and industrial brands. The agency works with clients including Microsoft, Sandvik Coromant, TD SYNNEX and Newsec, and has received multiple national and international awards for its cinematic and human-centered storytelling approach.